GSE209698 calcitriol D 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE209698_calcitriol_D_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE209698_calcitriol_D_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE209698_calcitriol_D_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE209698_calcitriol_D_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 15

Gene

long intergenic non-protein coding RNA 3040

Gene

neutrophil cytosolic factor 1C (pseudogene)

Gene

MAGI2 antisense RNA 3

Gene

tripartite motif containing 31

Gene

MIR3142 host gene

Gene

long intergenic non-protein coding RNA 472

Gene

cholesterol induced regulator of metabolism RNA

Gene

nicotinamide phosphoribosyltransferase pseudogene 1

Gene

MSC antisense RNA 1

  • Gene

    small nucleolar RNA host gene 15


  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    neutrophil cytosolic factor 1C (pseudogene)


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    tripartite motif containing 31



  • Gene

    long intergenic non-protein coding RNA 472


  • Gene

    cholesterol induced regulator of metabolism RNA


  • Gene

    nicotinamide phosphoribosyltransferase pseudogene 1


  • Gene

    MSC antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.